VERA

Vera Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 2/10
  • Value↑ 6/10
Vera Therapeutics sales and earnings growth
VERA Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -69.45%
  • FCF Y/Y↓ -78.20%
Vera Therapeutics gross and profit margin trends
VERA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -56.48%
Vera Therapeutics net debt vs free cash flow
VERA Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -38.8

Vera Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗